Showing results (151-160 of 276) with videos related to
Sort By:
Pageof 28
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 14, 1977
Is dopamine a neurohormone of the adrenal medulla? Studies with morphine stimulationS R Snider, C Miller, A L Prasad, et al.Life Sciences|January 1, 1989
Monoamine oxidase inhibitory properties of milacemide in ratsD D Truong, B Diamond, G Pezzoli, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Adductor laryngeal dystonia (spastic dysphonia): treatment with local injections of botulinum toxin (Botox)M F Brin, A Blitzer, S Fahn, et al.Neurology|January 1, 1990
Dopa-responsive dystonia: the spectrum of clinical manifestations in a large North American familyT G Nygaard, J M Trugman, J G de Yebenes, et al.Neurology|November 1, 1984
Genetic linkage analysis in primary torsion dystoniaS B Bressman, S Fahn, C Falk, et al.Pharmacology, Biochemistry, and Behavior|July 1, 1984
Reductions in pain thresholds and morphine analgesia following intracerebroventricular parachlorophenylalanineR J Bodnar, J H Kordower, A Reches, et al.Toxicology in Vitro : an International Journal Published in Association with BIBRA|August 25, 2010
Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitroN Giladi, M Sutton, B Lo, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Analysis of the clinical course of non-Jewish, autosomal dominant torsion dystoniaR E Burke, M F Brin, S Fahn, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Tardive akathisia: an analysis of clinical features and response to open therapeutic trialsR E Burke, U J Kang, J Jankovic, et al.AJR. American Journal of Roentgenology|August 1, 1987
Study of movement disorders and brain iron by MRJ N Rutledge, S K Hilal, A J Silver, et al.Pageof 28